Next Day Disclosure Returns
Filed with HKEX · Stock code 2256 · · 7 pages · English
Earlier from Abbisko Cayman
Later from Abbisko Cayman
- Change of company name
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- INSIDE INFORMATION - PIMJETMI (pimicotinib) Receive U.S. FDA Approval for TGCT
- Voluntary announcement - increase in shareholding of the company by the founder, the executive director, the chief executive officer and the chairman of the board of the company
- VOLUNTARY ANNOUNCEMENT - Abbisko Therapeutics Presents Preclinical Findings on Novel Selective CDK4 Inhibitor ABSK192 in Single-Agent and Combination Studies at 2026 ENA
Follow Abbisko Cayman into a list and get an email when it puts out news.
Follow Abbisko Cayman